The drug, known as Mounjaro (generic name is tirzepatide) created by Eli Lilly and Company for type 2 diabetes (and frequently prescribed off-label to aid in weight loss) It has been the focus of a wave of product liability suits within the U.S. Legal actions are still in the process of evolving, but the issues […]